Takeda, HUTCHMED gets EMA validation for marketing authorization application for Fruquintinib for Metastatic Colorectal Cancer Ruchika Sharma18 Jun 2023 12:15 PM ISTOsaka: Takeda and HUTCHMED (China) Limited have announced that the European Medicines Agency (EMA) has validated and accepted for regulatory...
Takeda Pharma's India operations become United Nations Global Compact signatory Ruchika Sharma27 Sept 2022 1:15 PM ISTNew Delhi: Takeda Pharmaceutical Company Limited has announced that its India operations have become a signatory of the United Nations Global Compact...
Takeda Pharma unveils haemophilia drug Adynovate in India MD Bureau17 May 2022 1:00 PM ISTThe prophylaxis treatment is named Adynovate and is an innovative extended half-life recombinant Factor VIII (rFVIII) treatment, using established...
Takeda Pharma gets USFDA nod for cancer treatment EXKIVITY Ruchika Sharma18 Sept 2021 10:00 AM ISTOsaka: Drugmaker, Takeda Pharmaceutical Company Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has...
Takeda starts Dengue vaccine regulatory submissions in EU, dengue-endemic nations Ruchika Sharma28 March 2021 10:00 AM ISTJapan: Takeda Pharmaceutical Company Limited has recently announced that the European Medicines Agency (EMA) has accepted the Company's...
Takeda concludes sale of Select OTC, Non-Core Assets to Hypera Pharma Ruchika Sharma1 Feb 2021 1:23 PM ISTTakeda intends to use the proceeds from the sale to reduce its debt and accelerate deleveraging towards its target of 2x net debt/adjusted EBITDA...
Takeda India named Top Employer in 2021 Ruchika Sharma26 Jan 2021 11:30 AM ISTNew Delhi: Takeda India has recently announced that the company has been named a Top Employer in 2021 by Top Employers Institute. This is also...
Takeda Pharma Chief asks transparency in virus vaccine rollout Ruchika Sharma21 Dec 2020 1:52 PM ISTTokyo: Pharmaceutical firms must be "very transparent" about the risks and benefits of vaccines in efforts to end the coronavirus pandemic, the head...
